Intelliscend Pharma Research And Consultancy Private Limited, a active private limited company, was established on 06 November 2013 in Thane, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74120MH2013PTC249826. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Arti Rajan Potdar (Director), Reena Roy (Director), Shruti Roy (Director). Past directors included Boddu Sneha Latha. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 703, Maitri Mari Gold Maitri Garden, Pokhran Road No 2, Thane, Maharashtra, 400601.
U74120MH2013PTC249826
249826
06 November 2013
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Intelliscend Pharma Research And Consultancy Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arti Rajan Potdar | Director | 06 Nov 2013 | Current |
| Reena Roy | Director | 06 Nov 2013 | Current |
| Shruti Roy | Director | 12 Feb 2021 | Current |
| Sunilendu Bhushan Roy | Managing Director | 20 Nov 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Intelliscend Pharma Research And Consultancy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.49% increase. The company also saw a substantial improvement in profitability, with a 143.18% increase in profit. The company's net worth Soared by an impressive increase of 34.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Intelliscend Pharma Research And Consultancy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Intelliscend Pharma Research And Consultancy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Intelliscend Pharma Research And Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intelliscend Pharma Research And Consultancy's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Intelliscend Pharma Research And Consultancy Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Intelliscend Pharma Research And Consultancy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Shruti Roy was appointed as a Director was appointed as a Director on 12 Feb 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
The activity Sunilendu Bhushan Roy was appointed as a Managing Director was appointed as a Managing Director on 20 Nov 2019 & has been associated with this company since 6 years 28 days . was completed.
Progress on Arti Rajan Potdar was appointed as a Director was appointed as a Director on 06 Nov 2013 & has been associated with this company since 12 years 1 month . was documented.
Reena Roy was appointed as a Director was appointed as a Director on 06 Nov 2013 & has been associated with this company since 12 years 1 month . was recorded as a recent event.
The CIN of Intelliscend Pharma Research And Consultancy Private Limited is U74120MH2013PTC249826.
Intelliscend Pharma Research And Consultancy Private Limited is headquartered at 703, Maitri Mari Gold Maitri Garden, Pokhran Road No 2, Thane, Maharashtra, 400601.
Intelliscend Pharma Research And Consultancy Private Limited was incorporated on 06 November 2013.
The current directors of Intelliscend Pharma Research And Consultancy Private Limited are
The primary industry of Intelliscend Pharma Research And Consultancy Private Limited is Professional, Scientific And Technical.
Intelliscend Pharma Research And Consultancy Private Limited is unlisted.
The authorized capital of Intelliscend Pharma Research And Consultancy Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Intelliscend Pharma Research And Consultancy Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX